How Medications Work: Restoring Balance, Fighting Infection & Prevention

Medicines intervene in disease processes through specific molecular mechanisms. Understanding these helps patients adhere to therapy and recognize effects.

Primary Mechanisms of Action

1. Antimicrobials – Target the Pathogen

  • Antibiotics: Inhibit bacterial cell wall synthesis (β-lactams), protein synthesis (macrolides, tetracyclines), DNA replication (fluoroquinolones), folate metabolism (sulfonamides). Bactericidal vs. bacteriostatic.
  • Antivirals: Block viral entry, replication (polymerase/protease inhibitors), assembly, or release. Narrow spectrum; resistance develops rapidly.
  • Antifungals: Target ergosterol synthesis (azoles), membrane integrity (polyenes), cell wall (echinocandins).
  • Antiparasitics: Diverse targets (e.g., artemisinin → heme detox in malaria).

2. Anti-Inflammatory & Immunomodulatory

  • NSAIDs: COX-1/2 inhibition → ↓ prostaglandins → ↓ pain, fever, inflammation. GI/renal/CV risks.
  • Corticosteroids: Glucocorticoid receptor → genomic & non-genomic effects → broad immune suppression. Dose/duration-dependent adverse effects.
  • DMARDs / Biologics: Target specific cytokines (TNF, IL-6, IL-1, IL-17, IL-23), B-cells (rituximab), T-cell co-stimulation (abatacept), JAK/STAT pathway.

3. Symptom Relief (Palliative, Not Curative)

  • Analgesics: Opioids (μ-receptor agonists), acetaminophen (central COX, unclear), adjuvant (gabapentinoids, TCAs, SNRIs).
  • Antiemetics: 5-HT3, NK1, dopamine, histamine, cannabinoid receptor antagonists.
  • Bronchodilators: β2-agonists, anticholinergics, theophylline.

4. Physiologic Replacement / Supplementation

  • Hormones: insulin, thyroxine, cortisol, sex steroids
  • Vitamins/minerals: B12, iron, vitamin D, folate
  • Enzymes: pancreatic enzyme replacement, factor concentrates

5. Disease-Modifying / Curative

  • Antineoplastics: Cytotoxic (DNA damage), targeted (kinase inhibitors, mAbs), immunotherapy (checkpoint inhibitors, CAR-T), hormonal.
  • Antivirals (curative): HCV direct-acting antivirals (DAAs) → SVR = cure.
  • Gene therapy: Viral vector (AAV, lentivirus) or non-viral delivery of functional gene (e.g., SMA, hemophilia B, retinal dystrophy).

6. Prevention – Vaccines

  • Active immunization: Antigen (protein, polysaccharide, mRNA, viral vector) → adaptive immunity (antibodies, memory T/B cells).
  • Passive immunization: Pre-formed antibodies (immune globulin, mAbs) – immediate, temporary protection.
  • Types: Live-attenuated, inactivated, subunit, toxoid, mRNA, viral vector, VLP.

Critical Principles for Patients

  1. Complete the course: Especially antibiotics—stopping early selects resistant mutants.
  2. Dosing schedule matters: Time-dependent (β-lactams) vs. concentration-dependent (aminoglycosides, fluoroquinolones).
  3. Interactions: CYP450 inducers/inhibitors, protein binding, renal/hepatic clearance. Include OTC, supplements, grapefruit.
  4. Adverse effects ≠ allergy: Nausea, diarrhea, rash (non-urticarial) are usually side effects. True allergy = IgE-mediated (anaphylaxis, urticaria, angioedema).
  5. Monitoring: Labs (LFTs, renal, CBC, levels), vitals, symptom diaries.

Medicines are tools, not magic. They work best with accurate diagnosis, appropriate selection, patient partnership, and follow-up.

Illness - Related Articles